News

How Esports World Cup moved from Saudi Arabia to Paris in 8 weeks

The Esports World Cup gets going in Paris after a last-minute move from Saudi Arabia. Is it any less controversial?

Singapore's Temasek boosts China exposure by $7.7 billion, biggest rise in five years, in AI-driven pivot

Temasek is repositioning its China portfolio toward AI-related hardware and infrastructure, robotics, biotech, energy transition.

Trump says he doesn't want anything to do with Spain: 'Cut off all trade'

NATO

U.S. President Donald Trump slammed Spain for not contributing enough to NATO, as he attended the defense alliance summit in Turkey.

China warns about AI risks with Anthropic's Claude Code

China said specific versions of Claude Code posed back-door vulnerabilities that could send sensitive information to a remote server.

SambaNova hits $11 billion valuation as investors back Nvidia chip challengers

NVDA, NVDAN, NVDACL, NVD, NVDD, 1NVDA, 4NVDA, 0R1I, 918422, NVDAUS

SambaNova is valued at $11 billion after fresh financing led by General Atlantic, as AI chip startups look to challenge Nvidia.

'Don't fool with us': NATO allies put on a united front as they prepare to meet Trump

NATO

NATO chief Mark Rutte said Wednesday that the alliance was entering its "NATO 3.0" era.

Samsung-backed AI chip firm Rebellions targets IPO in South Korea next year, CEO tells CNBC

AI, IPO

Sunghyun Park, CEO of Rebellions, told CNBC that the company is leaning toward a listing on the KOSPI over the KOSDAQ.

Singapore's Temasek hits record portfolio value, eyes more investment in AI, infrastructure and private credit

Over the course of its financial year, Temasek recorded a gain of S$49 billion and a 10.5% total shareholder return.

This former Apple executive is betting on Shenzhen, not Silicon Valley, to create the 'next Apple'

AAPL, AAPLN, AAPLCL, AAPLUS

Startups building consumer electronics will have a better shot at becoming the next Apple in Shenzhen than in Silicon Valley, said Will Wang, CEO of China's smart-glasses startup.

Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?

CRNX, SPRY

CRINETICS PHARM (CRNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.